Swedbank Ab Halozyme Therapeutics, Inc. Transaction History

Swedbank Ab

$95.2 Billion
Q3 2025

A detailed history of Swedbank Ab transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Swedbank Ab holds 147,162 shares of HALO stock, worth $9.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

147,162

Previous 157,162 6.36%

Holding current value

$9.59 Million

Previous $8.18 Million 32.01%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$52.92 - $78.28 $529,200 - $782,800	-10,000 Reduced 6.36%	147,162 $10.8 Million
Q2 2025 Jul 10, 2025	SELL	$47.91 - $70.14 $4.8 Million - $7.02 Million	-100,100 Reduced 38.91%	157,162 $8.18 Million
Q1 2025 Jun 23, 2025	SELL	$47.74 - $65.16 $1.25 Million - $1.7 Million	-26,100 Reduced 9.21%	257,262 $16.4 Million
Q4 2024 Jan 23, 2025	BUY	$42.57 - $61.09 $12.1 Million - $17.3 Million	283,362 New	283,362 $13.5 Million
Q3 2024 Oct 15, 2024	SELL	$51.3 - $64.42 $718,200 - $901,880	-14,000 Reduced 4.21%	318,362 $18.2 Million
Q2 2024 Jul 18, 2024	SELL	$37.81 - $52.4 $378,100 - $524,000	-10,000 Reduced 2.92%	332,362 $17.4 Million
Q1 2024 May 21, 2024	BUY	$33.68 - $41.95 $11.5 Million - $14.4 Million	342,362 New	342,362 $13.9 Billion
Q4 2023 Dec 09, 2024	BUY	$33.32 - $42.1 $316,540 - $399,950	9,500 Added 2.34%	415,362 $15.4 Million
Q3 2023 Dec 09, 2024	SELL	$36.46 - $44.03 $1.26 Million - $1.52 Million	-34,600 Reduced 7.86%	405,862 $15.5 Million
Q1 2023 Dec 09, 2024	SELL	$32.86 - $55.7 $6.22 Million - $10.5 Million	-189,332 Reduced 30.06%	440,462 $16.8 Million
Q4 2022 Dec 09, 2024	SELL	$40.06 - $59.44 $400,600 - $594,400	-10,000 Reduced 1.56%	629,794 $35.8 Million
Q3 2022 Dec 09, 2024	SELL	$38.53 - $51.78 $23.1 Million - $31.1 Million	-600,400 Reduced 48.41%	639,794 $25.3 Million
Q2 2022 Dec 09, 2024	SELL	$37.35 - $48.3 $28.7 Million - $37.1 Million	-767,300 Reduced 38.22%	1,240,194 $54.6 Million
Q1 2022 Dec 09, 2024	BUY	$31.97 - $41.06 $5.99 Million - $7.7 Million	187,494 Added 10.3%	2,007,494 $80.1 Million
Q4 2021 Dec 09, 2024	BUY	$31.82 - $40.75 $10.6 Million - $13.5 Million	331,838 Added 22.3%	1,820,000 $73.2 Million
Q3 2021 Dec 09, 2024	BUY	$38.47 - $46.42 $19.9 Million - $24.1 Million	518,162 Added 53.42%	1,488,162 $60.5 Million
Q2 2021 Dec 09, 2024	BUY	$38.84 - $51.31 $4.78 Million - $6.32 Million	123,093 Added 14.53%	970,000 $44 Million
Q1 2021 Dec 09, 2024	BUY	$39.51 - $51.45 $33.5 Million - $43.6 Million	846,907 New	846,907 $35.3 Million

Others Institutions Holding HALO

# of Institutions

631

Shares Held

127M

Call Options Held

408K

Put Options Held

384K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.08B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.

Account